AI Portfolio Summary
In 2025 Q4, Samsara BioCapital, LLC maintained a portfolio of 30 distinct positions. The most significant new addition to the portfolio was IVA, which now represents 2.49% of the total fund value. They heavily accumulated shares in SRRK, increasing their position by 22.9%. Conversely, Samsara BioCapital, LLC completely exited their position in SRZNW.
Total Positions
30
Quarter
2025 Q4
Top Holding
SRRK (31.3%)
Top 10 Concentration
91.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-30 of 30
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SRRK
80706P103
|
Healthcare | 31.35% | 27.29% |
#1
1
Prev: #2
|
8.5 | 1,284,756 | 22.9% |
P
S
|
6,897,652 | $303,841,571 |
$15.55
+175.3%
|
2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
MLYS
603170101
|
Healthcare | 21.98% | 31.01% |
#2
1
Prev: #1
|
6.0 | -392,133 | -6.3% |
P
S
|
5,871,018 | $213,059,243 |
$17.53
+103.7%
|
2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
KLRS
482929106
|
Healthcare | 11.27% | 8.64% |
#3
Prev: #3
|
7.0 | 1,500,000 | 13.1% |
P
S
|
12,948,081 | $109,281,804 |
$8.08
+2.8%
|
2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
SEPN
81734D104
|
Healthcare | 9.06% | 7.73% |
#4
Prev: #4
|
5.1 | no change | no change |
P
S
|
3,149,128 | $87,797,689 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALMS
022307102
|
Healthcare | 5.80% | 2.50% |
#5
1
Prev: #6
|
4.8 | 955,614 | 19.9% |
P
S
|
5,756,984 | $56,188,164 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NGNE
64135M105
|
Healthcare | 3.65% | 3.89% |
#6
1
Prev: #5
|
2.5 | no change | no change |
P
S
|
1,717,127 | $35,372,816 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IVA
46124U107
|
Healthcare | 2.49% | — |
#7
Prev: #—
|
4.5 | 5,194,805 | no change |
NEW
|
5,194,805 | $24,155,843 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GOSS
38341P102
|
Healthcare | 2.31% | 2.10% |
#8
Prev: #8
|
2.9 | 1,092,291 | 17.8% |
P
S
|
7,222,559 | $22,389,933 | 2019 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UPB
91678A107
|
Healthcare | 2.06% | 2.36% |
#9
2
Prev: #7
|
0.8 | -226,107 | -23.5% |
P
S
|
736,047 | $19,983,676 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AQST
03843E104
|
Healthcare | 1.67% | 1.82% |
#10
Prev: #10
|
1.7 | no change | no change |
P
S
|
2,500,000 | $16,150,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JBIO
008064206
|
Healthcare | 1.54% | 0.60% |
#11
7
Prev: #18
|
3.6 | 437,635 | 82.4% |
P
S
|
968,798 | $14,948,553 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTVT
918385204
|
Healthcare | 1.23% | 1.14% |
#12
1
Prev: #13
|
0.5 | -75,965 | -20.3% |
P
S
|
298,496 | $11,936,855 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RANI
753018100
|
Healthcare | 1.18% | — |
#13
Prev: #—
|
4.0 | 8,500,000 | no change |
NEW
|
8,500,000 | $11,475,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
697947109
|
Healthcare | 1.13% | 1.72% |
#14
3
Prev: #11
|
0.5 | -104,817 | -50.0% |
P
S
|
104,817 | $10,971,195 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
00370M103
|
Healthcare | 1.05% | 0.84% |
#15
2
Prev: #17
|
1.4 | no change | no change |
P
S
|
75,442 | $10,173,731 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XFOR
98420X202
|
Healthcare | 0.81% | — |
#16
Prev: #—
|
3.8 | 1,960,000 | no change |
NEW
|
1,960,000 | $7,840,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTX
65487U108
|
Healthcare | 0.67% | 1.02% |
#17
3
Prev: #14
|
0.8 | -260,369 | -6.9% |
P
S
|
3,507,666 | $6,489,182 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACLX
03940C100
|
Healthcare | 0.41% | 0.87% |
#18
2
Prev: #16
|
0.2 | -20,292 | -25.0% |
P
S
|
60,873 | $3,968,920 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STRO
869367201
|
Healthcare | 0.24% | 0.25% |
#19
4
Prev: #23
|
0.1 | -1,992,311 | -90.7% |
P
S
|
204,503 | $2,366,100 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTNM
21217B100
|
Healthcare | 0.09% | 0.88% |
#20
5
Prev: #15
|
0.0 | -498,897 | -87.4% |
P
S
|
72,245 | $825,760 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVB/WS
67080N119
|
Unknown | 0.00% | 0.00% |
#21
5
Prev: #26
|
0.5 | -9,214 | -6.9% |
P
S
|
124,119 | $40,959 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZNW
86889P117
|
Unknown | 0.00% | 0.00% |
Sold All 😨
(Was: #27) |
0.0 | -99,999 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BOLT
097702203
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #25) |
0.0 | -48,830 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
880881107
|
Healthcare | 0.00% | 0.13% |
Sold All 😨
(Was: #24) |
0.0 | -135,573 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RYTM
76243J105
|
Healthcare | 0.00% | 0.40% |
Sold All 😨
(Was: #22) |
0.0 | -30,285 | -100.0% |
CLOSED
|
— | $— | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZN
86889P208
|
Healthcare | 0.00% | 0.41% |
Sold All 😨
(Was: #21) |
0.0 | -241,400 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZYME
98985Y108
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #20) |
0.0 | -207,901 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AURA
05153U107
|
Healthcare | 0.00% | 0.47% |
Sold All 😨
(Was: #19) |
0.0 | -584,849 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVDL
G29687103
|
Healthcare | 0.00% | 1.35% |
Sold All 😨
(Was: #12) |
0.0 | -675,504 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LENZ
52635N103
|
Healthcare | 0.00% | 2.09% |
Sold All 😨
(Was: #9) |
0.0 | -343,012 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-30 of 30 holdings